Features of tryptophan kynurenine pathway metabolites alterations in coronary artery disease and heart failure

被引:0
|
作者
Alieva, R. B. Rano [1 ]
Fozilov, K. H. G. [1 ]
Belenkov, Y. U. N. [2 ]
Khabarova, N. V. [2 ]
Ageev, A. A. [2 ]
Appolonova, S. A. [2 ]
Kozhevnikova, M. V. [2 ]
机构
[1] Republican Specialized Sci Pract Med Ctr Cardiol, Tashkent, Uzbekistan
[2] IM Sechenov First Moscow State Med Univ, Innovat Sci Sch, Moscow, Russia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:626 / 627
页数:2
相关论文
共 50 条
  • [1] Kynurenine Pathway Metabolites as Potential Clinical Biomarkers in Coronary Artery Disease
    Gaspar, Renata
    Halmi, Dora
    Demjan, Virag
    Berkecz, Robert
    Pipicz, Marton
    Csont, Tamas
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [2] Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease
    Kozhevnikova, M., V
    Krivova, A., V
    Korobkova, E. O.
    Ageev, A. A.
    Shestakova, K. M.
    Moskaleva, N. E.
    Appolonova, S. A.
    Privalova, E., V
    Belenkov, Yu. N.
    KARDIOLOGIYA, 2022, 62 (11) : 40 - 48
  • [3] Relation of Kynurenine/Tryptophan with Immune and Inflammatory Markers in Coronary Artery Disease
    Ozkan, Yesim
    Sukuroglu, Murat Kadir
    Tulmac, Murat
    Kisa, Ucler
    Simsek, Bolkan
    CLINICAL LABORATORY, 2014, 60 (03) : 391 - 396
  • [4] Maternal Tryptophan and Kynurenine Pathway Metabolites and Risk of Preeclampsia
    Nilsen, Roy M.
    Bjorke-Monsen, Anne-Lise
    Midttun, Oivind
    Nygard, Ottar
    Pedersen, Eva R.
    Ulvik, Arve
    Magnus, Per
    Gjessing, Hakon K.
    Vollset, Stein Emil
    Ueland, Per Magne
    OBSTETRICS AND GYNECOLOGY, 2012, 119 (06): : 1243 - 1250
  • [5] Modulation of T cells by tryptophan metabolites in the kynurenine pathway
    Stone, Trevor W.
    Williams, Richard O.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2023, 44 (07) : 442 - 456
  • [6] Tryptophan degradation in psychosis: simultaneous measurement of tryptophan and kynurenine pathway metabolites by HPLC
    Clarke, G.
    Barry, S.
    Scully, P.
    Cryan, J. F.
    Dinan, T. G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S67 - S68
  • [7] Gut Microbiota and Metabolic Alterations Associated with Heart Failure and Coronary Artery Disease
    Yafarova, Adel A.
    Dementeva, Elena V.
    Zlobovskaya, Olga A.
    Sheptulina, Anna F.
    Lopatukhina, Elena V.
    Timofeev, Yuriy S.
    Glazunova, Evgeniya V.
    Lyundup, Aleksey V.
    Doludin, Yuriy V.
    Kiselev, Anton R.
    Shipulin, German A.
    Makarov, Valentin V.
    Drapkina, Oxana M.
    Yudin, Sergey M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (20)
  • [8] The impact of bariatric surgery on serum tryptophan–kynurenine pathway metabolites
    Kai Tai Derek Yeung
    Nicholas Penney
    Luke Whiley
    Hutan Ashrafian
    Matthew R. Lewis
    Sanjay Purkayastha
    Ara Darzi
    Elaine Holmes
    Scientific Reports, 12
  • [9] Alterations in the Kynurenine-Tryptophan Pathway and Lipid Dysregulation Are Preserved Features of COVID-19 in Hemodialysis
    Schuller, Max
    Oberhuber, Monika
    Prietl, Barbara
    Zugner, Elmar
    Prugger, Eva-Maria
    Magnes, Christoph
    Kirsch, Alexander H.
    Schmaldienst, Sabine
    Pieber, Thomas
    Brodmann, Marianne
    Rosenkranz, Alexander R.
    Eller, Philipp
    Eller, Kathrin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [10] Kynurenine Pathway Metabolites in Alzheimer's Disease
    Giil, Lasse Melvaer
    Midttun, Oivind
    Refsum, Helga
    Ulvik, Arve
    Advani, Rajiv
    Smith, A. David
    Ueland, Per Magne
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (02) : 495 - 504